Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Novo Nordisk (stock symbol: NVO) dividend yield (TTM) as of November 15, 2024 : 1.37%Average dividend yield, last 5 years: 1.30%